Shiga Toxin 2 Affects the Central Nervous System through Receptor Globotriaosylceramide Localized to Neurons
Open Access
- 1 November 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (9), 1398-1406
- https://doi.org/10.1086/591911
Abstract
Affinity-purified Shiga toxin (Stx) 2 given intraperitoneally to mice caused weight loss and hind-limb paralysis followed by death. Globotriaosylceramide (Gb3), the receptor for Stx2, was localized to neurons of the central nervous system (CNS) of normal mice. Gb3 was not found in astrocytes or endothelial cells of the CNS. In human cadaver CNS, we found Gb3 in neurons and endothelial cells. Mouse Gb3 localization was confirmed by immunoelectron microscopy. In Stx2-exposed mice, anti-Stx2-gold immunoreaction was positive in neurons. During paralysis, after Stx2 injection, multiple glial nuclei were observed surrounding motoneurons by electron microscopy. Also revealed was a lamellipodia-like process physically inhibiting the synaptic connection of motoneurons. Ca2+ imaging of cerebral astrocytic end-feet in Stx2-treated mouse brains suggested that the toxin increased neurotransmitter release from neurons. In this article, we propose that the neuron is a primary target of Stx2, affecting neuronal function and leading to paralysis.Keywords
This publication has 49 references indexed in Scilit:
- Shiga Toxin Facilitates Its Retrograde Transport by Modifying Microtubule DynamicsMolecular Biology of the Cell, 2006
- Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cellsJournal of Cell Science, 2004
- Induction of Apoptosis of Human Brain Microvascular Endothelial Cells by Shiga Toxin 1The Journal of Infectious Diseases, 2003
- Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculationNature Neuroscience, 2002
- Enterohemorrhagic Escherichia coli (EHEC) in Pediatric Hemolytic-Uremic Syndrome: A Prospedtive Study in Germany and Austria*Infection, 1999
- Capping and receptor‐mediated endocytosis of cell‐bound verotoxin (shiga‐like toxin) 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalizationJournal of Cellular Physiology, 1994
- Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 InfectionsThe Journal of Infectious Diseases, 1989
- Neurological Complications of Hemolytic-Uremic SyndromeJournal of Child Neurology, 1989
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988
- Neurological involvement in hemolytic‐uremic syndromeAnnals of Neurology, 1986